- Home
- DAKT vs RLAY Comparison
DAKT vs RLAY Comparison
Compare DAKT & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAKT
- RLAY
- Stock Information
- Founded
- DAKT 1968
- RLAY 2015
- Country
- DAKT United States
- RLAY United States
- Employees
- DAKT N/A
- RLAY N/A
- Industry
- DAKT Office Equipment/Supplies/Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DAKT Industrials
- RLAY Health Care
- Exchange
- DAKT Nasdaq
- RLAY Nasdaq
- Market Cap
- DAKT 710.0M
- RLAY 803.4M
- IPO Year
- DAKT 1994
- RLAY 2020
- Fundamental
- Price
- DAKT $19.95
- RLAY $6.11
- Analyst Decision
- DAKT Strong Buy
- RLAY Strong Buy
- Analyst Count
- DAKT 1
- RLAY 8
- Target Price
- DAKT $26.00
- RLAY $17.25
- AVG Volume (30 Days)
- DAKT 712.1K
- RLAY 1.6M
- Earning Date
- DAKT 09-10-2025
- RLAY 11-05-2025
- Dividend Yield
- DAKT N/A
- RLAY N/A
- EPS Growth
- DAKT 9.66
- RLAY N/A
- EPS
- DAKT 0.23
- RLAY N/A
- Revenue
- DAKT $749,361,000.00
- RLAY $8,355,000.00
- Revenue This Year
- DAKT $12.94
- RLAY $27.33
- Revenue Next Year
- DAKT $7.16
- RLAY $8.87
- P/E Ratio
- DAKT $85.13
- RLAY N/A
- Revenue Growth
- DAKT N/A
- RLAY N/A
- 52 Week Low
- DAKT $10.24
- RLAY $1.78
- 52 Week High
- DAKT $24.38
- RLAY $7.07
- Technical
- Relative Strength Index (RSI)
- DAKT 42.96
- RLAY 80.10
- Support Level
- DAKT $19.05
- RLAY $5.47
- Resistance Level
- DAKT $21.22
- RLAY $5.42
- Average True Range (ATR)
- DAKT 0.61
- RLAY 0.25
- MACD
- DAKT -0.45
- RLAY 0.09
- Stochastic Oscillator
- DAKT 7.92
- RLAY 99.36
About DAKT Daktronics Inc.
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).